600613Shanghai Shenqi Pharmaceutical Investment Management600613 info
$0.72info-1.55%24h
Global rank13804
Market cap$344.56M
Change 7d-
YTD Performance-33.11%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Shanghai Shenqi Pharmaceutical Investment Management (600613) Stock Overview

    Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, nourishing and soothing, tonic products, cold and cough, children's medicine, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidate injection, loquat cough granules, strong loquat decoction, loquat cough capsules, jinwugutong capsules, coral ringworm jing, jingwu capsules, quantianma capsules, yindanxintai dropping pills, etc. The company was founded in 1990 and is based in Shanghai, China.

    600613 Stock Information

    Symbol
    600613
    Address
    Changfa BuildingShanghai, 200003China
    Founded
    -
    Trading hours
    9:30 AM - 3:00 PM CST
    Website
    https://www.gzsq.com
    Country
    🇨🇳 China
    Phone Number
    86 21 5375 0009

    Shanghai Shenqi Pharmaceutical Investment Management (600613) Price Chart

    -
    Value:-

    Shanghai Shenqi Pharmaceutical Investment Management Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.7188554803903568
    N/A
    Market Cap
    $344.56M
    N/A
    Shares Outstanding
    479.32M
    N/A
    Employees
    1.57K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org